PC: Tecsys’ new survey shows that only 20% of healthcare leaders report having real-time visibility across pharmacy inventory ...

Instead of discovering a shortage at the point of care, that real-time usage and inventory trend allows the pharmacy teams to really see that risk earlier and adjust their sourcing, avoid those ...

In today’s Pharma Pulse, bipartisan lawmakers target PBM vertical integration, while pharma giants race to secure tariff-exempt pricing deals.

Hudicka also comments on practical steps can supply chain leaders take to build trust in AI-driven ecosystems without ...

Cell and gene therapies (CGTs) represent one of the most profound breakthroughs in modern medicine, offering the possibility ...

According to Reuters, some of the pharma companies that were not on the receiving end of President Trump’s May executive order (EO) 2 are interested in pursuing separate agreements in order to avoid ...

Rising recalls, tighter FDA enforcement, global supply chain dependencies, and rapid technology shifts are reshaping pharmaceutical quality and compliance—forcing manufacturers to rethink oversight, ...

By unifying data, workflows, and decision-making across partners, AI orchestration is enabling healthcare supply chains to ...

The pharmaceutical industry is comprised of multiple supply chains, due to its complexity. From an idea’s inception, to ...

Bandy: The statistics that we found within the survey is that four inc five, which is equivalent to about 79%, are saying that the drug shortages are what's causing the most disruption. We agree, drug ...

In today’s Pharma Pulse, the FDA issues a rare “Refusal-to-File" for Moderna’s influenza vaccine, while new research confirms GLP-1s act as potent tools against chronic inflammation.

1. Meijer Announces New Affordable Access to GLP-1 Medications. Meijer. February 10, 2026. Accessed February 11, 2026.